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A DNMT3A PWWP mutation leads to methylation
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DNA methyltransferases (DNMTs) deposit DNA methylation, which regulates gene
expression and is essential for mammalian development. Histone post-translational mod-
iﬁcations modulate the recruitment and activity of DNMTs. The PWWP domains of
DNMT3A and DNMT3B are posited to interact with histone 3 lysine 36 trimethylation
(H3K36me3); however, the functionality of this interaction for DNMT3A remains untested
in vivo. Here we present a mouse model carrying a D329A point mutation in the DNMT3A
PWWP domain. The mutation causes dominant postnatal growth retardation. At the mole-
cular level, it results in progressive DNA hypermethylation across domains marked by
H3K27me3 and bivalent chromatin, and de-repression of developmental regulatory genes in
adult hypothalamus. Evaluation of non-CpG methylation, a marker of de novo methylation,
further demonstrates the altered recruitment and activity of DNMT3AD329A at bivalent
domains. This work provides key molecular insights into the function of the DNMT3A-
PWWP domain and role of DNMT3A in regulating postnatal growth.
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DNA methylation is an epigenetic modiﬁcation that canregulate gene expression by inhibiting transcription factorbinding and mediating changes of chromatin conforma-
tion during development1,2. The inactive X chromosome,
imprinted genes, transposons, and repetitive elements are silenced
by DNA methylation, together with additional epigenetic mod-
iﬁcations. Furthermore, DNA methylation plays a key role in
regulating tissue-speciﬁc gene expression during development,
allowing differential cellular fate determination during lineage
speciﬁcation3–6. Methylation is added de novo to DNA at carbon-
5 of cytosine bases by DNA methyltransferase (DNMT) 3A,
DNMT3B and DNMT3C, although the last is conﬁned to the
murine male germline7–10. DNA methylation is subsequently
maintained by DNMT1, which localises at the replication fork,
recognises hemi-methylated DNA and methylates the nascent
strand11–14. The last member of the DNMT protein family is
DNMT3L, a catalytically inactive but essential co-factor for
gametic methylation events15–17. DNMT3A and DNMT3B show
highly conserved structural similarity and partial functional
redundancy, but there are biological contexts in which one pro-
tein predominates18–20. DNMT3B is the major DNMT required
for DNA methylation programming during embryogenesis and
Dnmt3b−/− mice die prior to embryonic day 11.5 (E11.5)18,20.
DNMT3A is predominantly responsible for DNA methylation in
oogenesis21,22 and neurogenesis23, and Dnmt3a−/− mice fail to
survive more than a few weeks after birth18. Mutations in human
DNMT3A are uniquely associated with haematological malig-
nancies and growth abnormalities24–27, while DNMT3B muta-
tions cause the Immunodeﬁciency, Centromeric instability, Facial
anomalies (ICF) syndrome28.
DNMT3A and DNMT3B can methylate cytosines in both CpG
and CpH contexts, but show rather limited speciﬁcity over
ﬂanking sequence composition29–31. Thus, post-translational
modiﬁcations (PTMs) of histone tails are believed to regulate
the recruitment of DNMT3s through interactions with their ADD
(ATRX-DNMT3-DNMT3L) and PWWP (Pro-Trp-Trp-Pro
motif) domains32. The ADD domain contains a motif homo-
logous to plant-homeodomain (PHD) zinc ﬁngers, and is shared
between DNMT3s and the alpha thalassaemia/mental retardation
syndrome X-linked (ATRX) protein33,34. The ADD domain of all
DNMT3s positively interacts with the amino-terminal tail of
histone 3 but is inhibited by histone 3 lysine 4 (H3K4) di-
methylation or tri-methylation, marks typically associated with
active chromatin34–37. The catalytic domain of DNMT3A is
autoinhibited by the ADD domain and upon the recognition of
unmethylated H3K4 a conformation change unmasks the cata-
lytic site37,38.
The PWWP domain is found in DNMT3A, DNMT3B and many
histone methyl-transferase or acetyl-transferase proteins39. In
DNMT3A and DNMT3B, the domain is required for their locali-
sation to major satellite repeats at pericentromeres40,41. A mutation
in the PWWP domain of DNMT3B was identiﬁed in a familial ICF
syndrome case, where patients showed loss of DNA methylation at
satellite repeat regions42. In general, PWWP domains have been
shown to interact with methylated histone tails, including but not
limited to H3K36me3, a mark found along actively transcribed
genes39,43,44. Biochemical studies, including chromatin precipitation
and peptide arrays, have reproducibly demonstrated that the
PWWP domain of DNMT3A interacts exclusively with
H3K36me2/344–47. Furthermore, a point mutation (D329A) in a
conserved aspartic acid residue in the PWWP domain abrogated
the ability of the DNMT3A-PWWP domain to bind H3K36me2
and H3K36me3 peptides or pull down H3K36me2/3-containing
native nucleosomes44–47. The D329A mutation also reduced the
preferential heterochromatin localisation of DNMT3A2 in trans-
fected cells and decreased catalytic activity on unmethylated native
nucleosomes44. Surprisingly, it was subsequently shown that when
assayed in mouse embryonic stem (ES) cells, the PWWP domain of
DNMT3B, but not of DNMT3A, was responsible for H3K36me3
recognition and associated gene body methylation, a mechanism
that was also successfully modelled in yeast48,49. However, whilst
mutations in the DNMT3B-PWWP domain or H3K36me3 deple-
tion resulted in loss of gene body methylation in ES cells and
yeast48,49, in epiblast-like stem cells de novo methylation was
reported to occur over transcribed regions in the absence of
H3K36me350. Thus, the role of the PWWP domain in targeting de
novo DNMTs to chromatin remains enigmatic and, in particular,
highlights the necessity for in vivo studies to investigate the
mechanisms targeting DNMT3A to chromatin and the function of
the DNMT3A PWWP domain.
In this study, we generate mice carrying a point mutation
(Dnmt3aD329A) in the DNMT3A-PWWP domain, which unex-
pectedly is gain of function and manifests phenotypically as
dominant postnatal growth retardation. We show that
DNMT3AD329A targets H3K27me3 and bivalent chromatin-
marked domains for DNA hypermethylation, which is asso-
ciated with loss of repression of developmental transcription
factor genes and altered histone PTM landscape. Thus, a muta-
tion in DNMT3A predicted to abrogate an interaction with
H3K36me2/3 causes a complex, gain-of-function phenotype
in vivo associated with recruitment of DNMT3A towards
H3K27me3-marked chromatin.
Results
Generation and phenotypic analysis of Dnmt3aD329A mice. To
investigate the in vivo signiﬁcance of the DNMT3A PWWP
domain, we generated a mouse carrying the previously in vitro
characterised D329A mutation44–47 in the endogenous Dnmt3a
locus (Fig. 1a and Supplementary Fig. 1). Mating Dnmt3a+/D329A
heterozygous males with wild-type females resulted in 19 out of
23 conﬁrmed pregnancies producing a litter, with an average litter
size of 8. In contrast, only 2 out of 19 conﬁrmed Dnmt3a+/D329A
female pregnancies produced a litter, with an average litter size of
2 (Supplementary Table 1). Paternal transmission litters showed
over 50% post-weaning survival, whilst there were no survivors
on maternal transmission. Dnmt3a+/D329A mothers consistently
went overdue and experienced labour dystocia. To assess whether
a problem in parturition accounted for the maternal transmission
deﬁcit, we performed caesarean section on Dnmt3a+/D329A
females and transferred offspring to foster mothers. This resulted
in 45% post-natal litter survival, suggesting that the parturition
failure is a dominant effect in females carrying the D329A
mutation (Supplementary Table 2), a phenotype that is not
explored further in this study.
We proceeded by transmitting the D329A mutation from
males crossed to females with heterozygous oocyte-speciﬁc
conditional ablation of Dnmt3a (Δ)21,22, thus generating four
genotypes amongst offspring: +/+, Δ/+, +/D329A and Δ/
D329A (where the maternal allele is listed ﬁrst); the last carries
the D329A mutation as the only functional Dnmt3a allele
(Fig. 1b). Notably, Dnmt3a+/D329A and Dnmt3aΔ/D329A mice
displayed signiﬁcant postnatal growth retardation, which was
more severe in the Dnmt3aΔ/D329A genotype and particularly
pronounced in males (Fig. 1c). In contrast, Dnmt3aΔ/+
offspring were indistinguishable from Dnmt3a+/+, indicating
no haploinsufﬁciency of Dnmt3a at a phenotypic level, and
showing that the D329A allele exhibited a gain of function. We
conﬁrmed that the growth deﬁcit of Dnmt3a+/D329A and
Dnmt3aΔ/D329A mice was not associated with reduced serum
growth hormone or insulin-like growth factor 1, major
modulators of postnatal growth (Supplementary Fig. 2).
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Transcriptional de-repression in Dnmt3aΔ/D329A hypothala-
mus. DNMT3A plays a predominant role in de novo methylation
during postnatal neurogenesis23,51 and the hypothalamus is
involved in regulation of body weight through endocrine function,
feeding behaviour and energy homoeostasis52,53. We therefore
evaluated potential gene dysregulation by performing RNA-seq on
adult (14-week) hypothalamus. The D329A allele did not cause a
statistically signiﬁcant change in Dnmt3a transcript levels, or
affect the abundance of other Dnmt or Tet transcripts (Supple-
mentary Fig. 3). However, we identiﬁed 259 differentially
expressed genes (DEGs) between Dnmt3aΔ/D329A and Dnmt3a+/+
(Fig. 1d and Supplementary Data 1). Gene ontology (GO) analysis
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Fig. 1 Phenotypic description of mice carrying the Dnmt3aD329A allele. a Schematic representation of the DNMT3A protein isoforms and location of the
base substitution, coloured red, introduced to generate the D329A mutation. NCBI IDs: CCDS36397.1, CCDS25784.1. Known domains are indicated by
coloured boxes, based on the PROSITE database; numbers indicate amino acid residues. b Breeding scheme used to generate offspring of four different
genotypes. +; wild-type allele; ﬂ: Dnmt3a containing loxP sites surrounding exon 18; Δ: loxP sites after recombination leading to deletion of exon 18; Zp3-Cre:
oocyte-speciﬁc Zp3 promoter-driven Cre recombinase21,22; D329A: a Dnmt3a allele point missense mutation in exon 8. c Growth curves indicating change in
body weight of male and female mice of different genotypes over the indicated post-natal weeks. Mixed model ANOVA (KR-method) shows overall
signiﬁcant change dependent on genotype and time in both sexes (p < 0.001, df(males)= 15,229.48, df(females)= 15,142.15), F= 0). Subsequent pairwise
Bonferroni-adjusted t-test comparisons show that Dnmt3aΔ/D329A males become signiﬁcantly underweight at week 4 (p < 0.001), and Dnmt3a+/D329A at
week 6 (p < 0.001). Dnmt3aΔ/D392A females become signiﬁcantly underweight starting from week 4 (p= 0.002), with the exception of week 8 (p= 0.095).
Dnmt3a+/D329A females do not show signiﬁcant change. n values are given in Supplementary Table 3. Error bars indicate standard error of the mean. Raw
data are provided in Source Data. d Volcano plot showing gene expression fold change and its signiﬁcance between Dnmt3a+/+ and Dnmt3aΔ/D329A adult
(14-week) hypothalamus. Differentially expressed genes were determined using DEseq (p < 0.01, Benjamini–Hochberg multiple comparisons correction).
n(+/+)= 5, n(Δ/D392A)= 4. Selected genes showing the most signiﬁcant and highest fold change are named. e Gene ontology (GO) analysis of
differentially expressed genes; only signiﬁcant terms are shown. Benjamini–Hochberg corrected p-value < 0.1 was used as a threshold
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indicated that upregulated genes were enriched in transcriptional
regulators (Fig. 1e and Supplementary Data 2). Although down-
regulated genes did not show any signiﬁcant GO term enrichment,
amongst them were Ghsr, Bdnf, Sirt1 and Cartpt, key hypotha-
lamic regulators of feeding and energy expenditure54–57. More
striking, however, was the observation that a number of repressed
transcription factor genes, such as Tal1, Pou4f1, Wt1, Hoxa7 and
Hoxd8, showed dramatic upregulation in the Dnmt3aΔ/D329A
hypothalamus (Fig. 1d). While growth retardation in the mutants
could result from altered expression of the aforementioned
metabolic regulators or transcription factors, it is important to
highlight that, unusually, the most signiﬁcant transcriptional
changes were observed among genes that are normally deeply
repressed in adult tissues.
The DNMT3AD329A mutant causes aberrant gain of methyla-
tion. To determine whether changes observed in gene expression
were due to aberrant DNA methylation, we performed genome-
wide DNA methylation proﬁling in adult (14-week) hypothala-
mus. Although the global DNA methylation level was similar
across the four genotypes, with mean levels of 77.2%, 75.1%,
77.2%, and 75% in Dnmt3a+/+, Dnmt3aΔ/+, Dnmt3a+/D329A, and
Dnmt3aΔ/D329A, respectively, they could be separated by principal
component analysis (Fig. 2a, Supplementary Fig. 4a, b). Indivi-
dual samples clustered together into groups based on genotype,
while genotype groups separated spatially, indicating high
reproducibility between animals of each genotype, but distinct
global methylation patterns between genotypes. The slight
reduction in methylation in Dnmt3aΔ/+ in comparison to
Dnmt3a+/+ suggested haploinsufﬁciency at a molecular level. A
similar effect was observed between Dnmt3a+/D329A and
Dnmt3aΔ/D329A, suggesting that DNMT3A dosage is important
for ~2% of genome-wide DNA methylation levels in this tissue.
As gene bodies are normally marked by H3K36me3, the
putative target of the DNMT3A-PWWP domain, we ﬁrst assessed
methylation over gene bodies. All genes were highly methylated
irrespective of expression level (Supplementary Fig. 4c), demon-
strating that the Dnmt3aD329A mutation does not profoundly
affect gene body DNA methylation, although a similar haploin-
sufﬁciency effect to that seen in global methylation was observed
in comparing the four genotypes. This effect extended to
promoter regions, but for CpG island (CGI) containing
promoters the trend was reversed, with higher levels of DNA
methylation in the presence of the Dnmt3aD329A allele (Supple-
mentary Fig. 4d). Surprised by this ﬁnding, we used the EdgeR
tool to compare Dnmt3a+/+ and Dnmt3aΔ/D329A, which
identiﬁed 4184 statistically differentially methylated regions
(DMRs) (p(adj) < 0.01). Strikingly, the majority of DMRs (3584;
85.7%) showed gain of DNA methylation in Dnmt3aΔ/D329A
compared to Dnmt3a+/+ (Fig. 2b–e Supplementary Figs. 5, 6 and
Supplementary Data 3). To discriminate the effects of haploin-
sufﬁciency versus the D329A mutation, and whether hypomethy-
lated domains were a result of the mutation, we used the same
statistical tool to identify DMRs between Dnmt3aΔ/+ and
Dnmt3aΔ/D329A, and between Dnmt3a+/+ and Dnmt3aΔ/+. In
the Dnmt3aΔ/+ and Dnmt3aΔ/D329A comparison, which corrects
for the number of alleles, only 75 out of 4603 DMRs were
hypomethylated, whereas in the Dnmt3a+/+ and Dnmt3aΔ/+
comparison, 328 out of 351 DMRs were hypomethylated (Fig. 2f,
g and Supplementary Data 4 and 5). This demonstrates that
hypomethylation was primarily a result of haploinsufﬁciency,
whilst hypermethylation was caused by the DNMT3AD329A
mutation.
Analysis of DNA methylation of DEGs showed that only about
one in ﬁve misregulated genes were associated with DNA
methylation changes (Supplementary Figs. 7–9), suggesting a
substantial proportion of DEGs may be attributable to indirect,
downstream effects of direct targets. A cluster of genes that
showed a gain of DNA methylation over both promoter and gene
body stood out in the analysis (Supplementary Fig. 7). Many of
these were the same developmental transcription factor genes that
are normally strongly repressed in adult hypothalamus, but which
are paradoxically derepressed in Dnmt3aΔ/D329A (e.g., Hoxa7,
Hoxd8, Pou4f1, Tal1, and Wt1). It is important to note that
despite the increase in DNA methylation over these genes, their
transcription start sites remained relatively less methylated than
the surrounding regions (Supplementary Fig. 10).
Taken together, these ﬁndings suggest that the Dnmt3aD329A
allele is a driver of aberrant gain of DNA methylation and
derepression of a subset of associated genes; consequently, all
subsequent analyses are focussed on hypermethylated DMRs.
DNA methylation alterations occur in multiple tissues. To
assess whether the observed DNA methylation abnormalities
were tissue-speciﬁc, we also analysed DNA methylation in adult
(14-week) pituitary and liver. We chose pituitary because of its
functional link with hypothalamus in growth regulation58 and
liver as an unrelated and relatively homogeneous tissue. As with
hypothalamus, the four Dnmt3a genotypes had similar global
DNA methylation levels in these tissues, but could be separated
by principal component analysis (Fig. 3a, b). Using the EdgeR
tool to identify DMRs, both liver and pituitary showed an excess
of hypermethylated sites similar to, although to a lesser extent
than, the hypothalamus (Supplementary Data 6–9). Moreover,
hypermethylation in both tissues was speciﬁcally related to the
presence of the D329A allele (Fig. 3c, d). Strikingly, there was
substantial overlap of DMRs between the three tissues, particu-
larly amongst hypermethylated probes (Fig. 3e). The occurrence
of shared hypermethylated DMRs, albeit with tissue-speciﬁc dif-
ferences in magnitude, raised the question of whether aberrant
DNA methylation arose early in embryogenesis prior to cell
lineage speciﬁcation or independently in each tissue.
DNA methylation gain is progressive in postnatal develop-
ment. The major phase of DNA methylation establishment in
mice occurs during early post-implantation development
(E4.5–E6.5)5,59. To address the possibility that aberrant methy-
lation was established during this phase of embryonic remethy-
lation, we collected E7.5 mouse epiblasts (Epi) from embryos of
all four genotypes. Global methylation was more variable in
Dnmt3a+/D329A and Dnmt3aΔ/D329A embryos than Dnmt3a+/+
and Dnmt3aΔ/+ (Supplementary Fig. 11). Overall, methylation in
Dnmt3a+/D329A and Dnmt3aΔ/D329A embryos was lower than
wild-type at all genomic features; however, at CGI promoters this
may be attributable to a haploinsufﬁciency effect as reduced DNA
methylation was also observed in Dnmt3aΔ/+ embryos. We used
EdgeR to assess Dnmt3a+/+ and Dnmt3aΔ/+ embryos and
identiﬁed 136 DMRs out of a total of 108,212 tiles (0.13%; Sup-
plementary Data 10). All but two DMRs were overlapping a CGI,
again pointing to the potential role of DNMT3A in CGI
methylation during early development. Comparison between
Dnmt3a+/+ and Dnmt3aΔ/D329A embryos identiﬁed only ﬁve
signiﬁcantly hypomethylated tiles out of a total of 108,212
(0.005%; Supplementary Data 11). This suggests that the presence
of mutant DNMT3A results in stochastic delay in de novo
methylation across genomic regions rather than any locus spe-
ciﬁcity. In agreement with this, embryos did not cluster based on
genotype (Supplementary Fig. 11b–d). Crucially, there was no
evidence of hypermethylation in Dnmt3aΔ/D329A mutants at E7.5
(Supplementary Fig. 11e–j), suggesting that it was not set during
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the major wave of post-implantation de novo methylation. In
view of this result, and because hypothalamic neurons undergo
further epigenetic modelling during postnatal maturation51, we
next assessed methylation in hypothalamus at postnatal days 1
and 25 (P1 and P25). This showed a progressive gain of DNA
methylation across the domains destined to be hypermethylated
in Dnmt3aΔ/D329A adults (Fig. 4a–d). Together, these ﬁndings
suggest that the aberrant gain of DNA methylation caused by the
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D329A allele occurs in tissues independently during postnatal
development rather than early development.
Hypermethylated loci are enriched in transcription factors. To
identify what was shared amongst loci anomalously methylated
by DNMT3AD329A, we evaluated their genomic properties. As
previously observed, hypermethylated DMRs were strongly
enriched in CGIs (Fig. 5a). We also noticed that many hyper-
methylated DMRs fell within large normally unmethylated
genomic regions (Fig. 2e), features previously described as
methylation ‘valleys’ or ‘canyons’ that are conserved amongst
vertebrates60,61. Of the 1104 canyons originally deﬁned in
hematopoietic stem cells60, 779 were also hypomethylated in
wild-type hypothalamus (Supplementary Data 12) and displayed
a substantial increase in DNA methylation in Dnmt3aΔ/D329A
(Fig. 5b). GO analysis indicated that genes within hypermethy-
lated DMRs in Dnmt3aΔ/D329A hypothalamus were strongly
enriched in transcription factors and regulators of morphogenesis
and differentiation (Fig. 5c and Supplementary Data 13).
Gain of DNA methylation is linked to H3K27me3. Develop-
mental transcription factor genes that showed dysregulated
expression and DNA methylation are embedded in methylation
canyons typically marked by bivalent chromatin and
silenced by Polycomb repressor complexes60,62,63. Thus, we
hypothesised that DNMT3AD329A hypermethylated DMRs would
be enriched in H3K4me3 and H3K27me3. To assess this, we
generated H3K4me3, H3K27me3, and H3K36me3 chromatin
immunoprecipitation-sequencing (ChIP-seq) datasets from adult
(14-week) hypothalamus. Overall, these histone marks exhibited
strong correlation between Dnmt3a+/+ and Dnmt3aΔ/D329A
samples (Supplementary Fig. 12), indicating no marked shift in
the genomic distribution of these marks in the presence of the
Dnmt3aD329A allele. Strikingly, however, whereas hypermethy-
lated and hypomethylated DMRs were not obviously separated in
terms of enrichment levels for H3K4me3 or H3K36me3, there
was a clear separation in their enrichment for H3K27me3
(Fig. 6a–c).
To explore this effect more rigorously, we called H3K36me3,
H3K27me3, and H3K4me3 peaks and observed that 70.4% of
hypermethylated DMRs were bivalent, i.e., contained both
H3K27me3 and H3K4me3 peaks, with an additional 26.3%
containing H3K27me3 only peaks (Fig. 6d), suggesting that
DNMT3AD329A is preferentially recruited to H3K27me3-marked
chromatin and is able to methylate bivalent DNA marked by
H3K4me3 in the presence of H3K27me3. In contrast, only 11
(1.8%) hypomethylated and 74 (2.1%) hypermethylated domains
overlapped H3K36me3 peaks, again indicating that DMRs were
not associated with this histone mark. We then sought to
discriminate between two possible mechanisms to explain the
aberrant targeting of DNMT3AD329A to Polycomb-associated
methylation canyons: (1) the D329A mutation leads to promis-
cuous localisation and activity of DNMT3A due to a loss of
association with H3K36me3-marked chromatin; or (2)
DNMT3AD329A is selectively recruited to H3K27me3-marked
chromatin. To do this, we looked ﬁrst at DNA methylation at
gene bodies with low (bottom quintile) or high (top quintile)
levels of H3K36me3. In a comparison of the four genotypes, we
observed no signiﬁcant differences in gene body DNA methyla-
tion associated with the Dnmt3aD329A allele (Fig. 6e). We then
selected regions that are hypomethylated in Dnmt3a+/+
hypothalamus (methylation level below 10%; 4.6% of the genome;
Fig. 6f) and partitioned hypomethylated probes based on low or
high levels of enrichment of H3K4me3, H3K27me3, or
H3K36me3. By this analysis, neither the presence nor absence
of either H3K4me3 or H3K36me3 were associated with DNA
hypermethylation by DNMT3AD329A (Fig. 6g, h). In contrast,
hypomethylated regions highly enriched in H3K27me3 were
preferentially hypermethylated (Fig. 6i). This suggests that
hypomethylation of genomic domains per se is not sufﬁcient to
recruit and activate DNMT3AD329A. Furthermore, bivalent
regions marked by both H3K27me3 and H3K4me3 also showed
a substantial gain in DNA methylation (Fig. 6i), although to a
lesser degree than H3K27me3 alone, suggesting the presence of
H3K4me3 remains antagonistic to DNMT3AD329A activity.
Together these results support the conclusion that
DNMT3AD329A is selectively recruited to H3K27me3-marked
chromatin.
Because H3K27me3 and DNA methylation show mutual
exclusivity in some genomic contexts64–66, we were interested
whether the histone landscape would be altered, with DNA
methylation replacing H3K27me3 at hypermethylated DMRs.
Although the levels of DNA methylation gain were marginally
associated with loss of H3K27me3 (Fig. 6j), these marks
appeared to co-exist with hypermethylated domains retaining a
substantial amount of H3K27me3, even at CGIs, and we
observed that the extent of DNA methylation gain correlated
better with initial enrichment of H3K27me3 over the locus than
its loss (Fig. 6k). Finally, we were able to use the ChIP-seq data
to evaluate that for a subset of DEGs there were associated
changes in promoter H3K4me3 (Fig. 6l). These ﬁndings
support the link between H3K27me3 and abnormal localisation
of DNMT3AD329A, and suggest that the normal histone
landscape is affected by the aberrant gain in DNA methylation
(Fig. 7).
Non-CpG methylation shows altered DNMT3AD329A recruit-
ment. Non-CpG (CpH) methylation becomes particularly abun-
dant in neural tissues, where it is established postnatally by
Fig. 2 DNA methylation changes in mice carrying Dnmt3aD329A allele. a Beanplots indicating whole genome methylation levels in hypothalamus of adult
(14 week, male) mice carrying the alleles shown. Boxplot shows median value and 25–75th percentiles, whiskers show lowest and highest observation,
excluding outliers. Raw data are provided in Source Data. b Scatterplot showing correlation of methylation levels of individual tiles between Dnmt3a+/+ and
Dnmt3aΔ/D329A mice. Differentially methylated probes were determined using the EdgeR proportion statistic in SeqMonk (p < 0.01 corrected for multiple
comparisons using Benjamini–Hochberg, methylation difference≥ 20%). Pie-chart indicates how many of DMRs are hyper-methylated or hypo-methylated
in Dnmt3aΔ/D329A. n= 3 for each genotype. c, d Beanplots indicating DNA methylation levels over hypermethylated (c) and hypomethylated (d) DMRs.
Boxplot shows median value and 25–75th percentiles, whiskers show lowest and highest observation, excluding outliers. Source data are listed in
Supplementary Data 3. e Representative genome browser region showing the Hoxd hypermethylated domain. De-repressed gene Hoxd8 promoter region is
shaded. For gene and mRNA tracks, the colour indicates direction, where red is a forward strand and blue is a reverse strand. Colour-coded blocks are tiles
of 100-CpG positions. Error bars indicate standard deviation. f, g Scatterplots showing correlation between methylation levels of 100-CpG tiles in 14-week
adult male hypothalamus of f Dnmt3aΔ/+ and Dnmt3aΔ/D329A, and g Dnmt3a+/+ and Dnmt3aΔ/+. Differentially methylated tiles were determined using the
EdgeR proportion statistic in SeqMonk (p < 0.01 corrected for multiple comparisons using Benjamini-Hochberg, methylation difference≥ 20%). The pie-
chart indicates the number of DMRs identiﬁed. In a–g, Hypo: hypomethylated, hyper: hypermethylated. Tiles of 100-CpG positions. n(+/+, Δ/+, Δ/
D329A)= 3, n(+/D329A)= 2. CGI: CpG island, DMR: differentially methylated region
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DNMT3A67–69. Importantly, CpH methylation is not maintained
at DNA replication, so its presence is a record of de novo
methylation since the last replication event. Thus, we investigated
CpH methylation in adult hypothalamus as a read-out of
DNMT3A localisation and activity (Fig. 8a). CpH methylation
levels showed strong evidence for haploinsufﬁciency at the
molecular level, as we observed very similar decreases in
global levels in Dnmt3aΔ/+ compared to Dnmt3a+/+, and
Dnmt3aΔ/D329A compared to Dnmt3a+/D329A (Fig. 8a, b).
The smaller global reduction between Dnmt3a+/D329A and
Dnmt3a+/+ and between Dnmt3aΔ/D329A and Dnmt3aΔ/+ sug-
gests some decrease in methyltransferase activity by the mutant
protein. Strikingly, however, the pattern over hypermethylated
DMRs was reversed, with Dnmt3a+/D329A and Dnmt3aΔ/D329A
showing increased CpH methylation compared to Dnmt3a+/+
and Dnmt3aΔ/+, respectively (Fig. 8a, c). Comparing relative CpH
methylation across prenatal and postnatal development showed
that this effect ﬁrst becomes evident in the P1 hypothalamus
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Fig. 3 DNA methylation in adult pituitary and liver. a Beanplots indicating whole genome methylation levels in pituitary and liver of 14-week adult male
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observation, excluding outliers. Raw data are provided in Source Data. b PCA plots showing clustering of individual pituitary and liver samples into separate
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(Fig. 8d). In summary, these data demonstrate that recruitment
and subsequent activity of the DNMT3AD329A protein is
aberrantly localised preferentially to bivalent chromatin in the
postnatal brain.
Discussion
Here we describe a gain-of-function mutation in the PWWP
domain of DNMT3A that results in postnatal growth deﬁ-
ciency in mice and, at a molecular level, aberrant DNA
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methylation of genomic domains harbouring H3K27me3-
silenced developmental regulatory genes. We demonstrate
that the gain of DNA methylation occurs speciﬁcally during
postnatal development and is likely to be a consequence of an
altered association of the mutant DNMT3A with chromatin.
Furthermore, we observed transcriptional de-repression of a
subset of the associated genes, suggesting the aberrant locali-
sation of DNA methylation to these genomic regions para-
doxically results in their activation.
The DNMT3A-PWWP domain has been described to bind to
H3K36me2 and H3K36me3 in vitro, an interaction that was blocked
by targeted mutations, including D329A27,44,47. In Dnmt3aD329A
E7.5 embryos, we observed a stochastic delay in de novo methylation
that was not localised to particular genomic areas. In adult tissues,
however, we did not observe a loss of DNA methylation attributable
to the D329A mutation and ﬁnd no evidence that this mutation
alters DNA methylation levels at regions enriched for H3K36me3,
suggesting the delays observed in embryonic development do not
persist. Together, these ﬁndings suggest that the function of
DNMT3A in vivo is not necessarily reliant on its association with
H3K36me2/3, but that the D329A mutant protein may have reduced
methylase activity due to an altered association with chromatin or
catalytic activity. Subsequently, the delay in de novo methylation may
be recovered with time or DNMT3B may be able to compensate
during embryogenesis, supported by previous observations that
DNMT3A and DNMT3B have partial redundancy in the post-
implantation embryo18,50.
In addition to an interaction with H3K36me2/3, wild-type
DNMT3A has been found to associate speciﬁcally with
H3K27me3-marked shores of bivalent CGIs70,71. In our study,
the DNMT3AD329A mutant aberrantly methylates bivalent and
H3K27me3-marked genomic domains in postnatal development.
This hypermethylation is selective towards polycomb repressive
complex (PRC2)-mediated H3K27me3 domains rather than
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unmethylated regions of the genome in general, supporting an
association between the PWWP domain and H3K27me3
in vivo27. Nonetheless, direct interaction evidence between
DNMTs and H3K27me3 from biochemical experiments is
limited27,44,47,70, and thus the nature of this association will need
to be explored further.
DNA methylation and H3K27me3 are repressive marks that
have been widely reported to be mutually exclusive67,72,73.
However, this effect is not observed genome-wide; it is largely
restricted to regions containing CGIs66,74 and mediates the gen-
eration of large hypomethylated canyons or valleys across these
CGI-rich domains, such as the Hox clusters60,61. The regulation
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of these hypomethylated, H3K27me3-marked domains involves a
complex and still poorly understood interplay between PRC2,
DNMT3A, and DNA demethylases (TET proteins) (Fig. 9a).
There has been considerable focus on what deﬁnes the boundaries
of these domains, which is thought to rely on a dynamic equili-
brium between DNMT3A and TET proteins60,61,70,71. Knock-
outs of either protein strongly affect domain boundaries, whilst
the core regions remain protected through an unknown
mechanism. The protection of these domains is exempliﬁed by a
Dnmt3b overexpression mouse model that shows aberrant gain of
methylation genome-wide and a marginal increase (<10%) across
H3K27me3-marked domains75. While DNMT3s have a strong
afﬁnity towards H3K36me2/3, there may be a weak afﬁnity
towards H3K27me3, such that the abundance of different
DNMT3s and their interacting proteins could modulate chro-
matin localisation depending on the cellular context. A direct
association of DNMTs with H3K27me3 regions in some contexts
is supported by the observation that DNA methylation is
dependent on the deposition of H3K27me3 at a subset of CGIs in
extraembryonic ectoderm76 and cancer77. At this time, it is
unclear how the D329A mutation may have altered the properties
of DNMT3A to enhance its interaction with H3K27me3 and/or
with members of the PRC2, allowing it not only to target the
boundaries but the protected core of bivalent domains as well as
(Fig. 9b). One possibility is that H3K36me2/3 acts as a sink for
wild-type DNMT3A, and loss of afﬁnity for this interaction
would permit mutant protein to localise to bivalent chromatin
exclusively, tipping the balance between DNMT3A and TETs at
those sites.
As both DNA methylation and H3K27me3 are repressive
modiﬁcations, it is rather surprising to see de-repression of
strongly silenced genes in Dnmt3aΔ/D329A hypothalamus, when
methylation is acquired and H3K27me3 is maintained to some
extent. In a similar observation, Hox genes were activated when
DNA methylation was targeted to gene bodies within these
regions in tumours78. Yet, in contrast, we ﬁnd that DNA
methylation is acquired across the whole domain, not just gene
bodies. Together, these ﬁndings suggest that aberrant targeting
of DNA methylation to the core of bivalent domains could lead
to displacement of PRC2, disrupting the repressive chromatin
conformation. This is supported by the observation that DNA
methylation generally, albeit not always, inhibits PRC2 binding
and activity in vitro65,79 and can block the deposition of
H3K27me366. Furthermore, aberrant methylation gain over
PRC2 domains leads to loss of H3K27me3 when DNMT3B
is overexpressed75. The H3K27me3 that remains at the
hypermethylated DMRs we observed could be explained by
lower histone turnover rates in non-replicative neurons or
could be maintained by PRC2 variants that show afﬁnity for
methyl-CpG79.
Despite Dnmt3a being expressed throughout prenatal and
postnatal development, we only observed hypermethylation of
DNA in the presence of the Dnmt3aD329A allele postnatally. In
prenatal development, the predominant transcript isoform is
Dnmt3a2, while in postnatal tissues it is Dnmt3a119,70. The
presence of the mutation speciﬁcally in the longer protein derived
from isoform 1 may enable the aberrant targeting to bivalent
chromatin, especially since DNMT3A1 has been found to
associate with H3K27me3-marked shores of bivalent CGIs70,71.
Alternatively, Dnmt3b is very highly expressed throughout early
prenatal development and is responsible for the majority of de
novo methylation20. Therefore, in this context, the aberrant
localisation of the mutant DNMT3A may be rescued by hetero-
dimerisation with DNMT3B80,81.
Recently, point mutations in the PWWP domain of human
DNMT3A have been described in a speciﬁc class of tumour—
hereditary paraganglioma82 and in microcephalic dwarﬁsm27,
including a substitution in the amino acid residue orthologous
to murine D329. In both cases, the mutations are associated
with gain of methylation of H3K27me3-marked domains con-
taining developmental regulatory genes, similar to the ﬁndings
in our study. Moreover, a W326R mutation induced in mice
exhibits a similar dominant growth effect and hypermethyla-
tion, although the molecular mechanisms remain to be fully
explored27. Importantly, in our study, the detailed analysis of
the ectopic DNA methylation in relation to chromatin data
suggests a positive recruitment of the DNMT3A-PWWP
mutant protein to H3K27me3-marked domains, rather than
non-selective relocalisation from H3K36me2/3 sites favoured
by Heyn et al.27, as we do not observe gains of DNA methy-
lation across other genome features. Nevertheless, future stu-
dies will be invaluable in elucidating the biochemical properties
of the mutated DNMT3A PWWP domain.
In summary, we provide a characterisation of the growth
phenotype and underlying molecular changes of the
Dnmt3aD329A mutant mouse model. We demonstrate that the
mutant DNMT3A exhibits highly speciﬁc, altered targeting to
H3K27me3-marked chromatin. The aberrant gain in DNA
methylation across these domains is only observed in postnatal
development, suggesting that the DNMT3A1 isoform may be
uniquely affected or that the absence of DNMT3B in adult tissues
unmasks this effect. This study provides further insights into the
Fig. 6 Link between H3 post-translational modiﬁcations and aberrant DNA methylation. a–c Scatterplots showing correlation between enrichments for
a H3K4me3; b H3K27me3; c H3K36me3 between Dnmt3a+/+ and Dnmt3aΔ/D329A hypothalamus, with the tiles overlapping hypermethylated (blue) and
hypomethylated (red) DMRs indicated. n= 3 each genotype. Tiles of 2 kb with a step of 1 kb were used for analyses. d Percentages of hypermethylated and
hypomethylated DMRs (100-CpG) that overlap bivalent (H3K4me3 and H3K27me3), H3K27me3 only, H3K4me3 only and H3K36me3 peaks, or regions
with no mark. A random set of 100-CpG tiles (excluding DMRs) was used as a whole genome representative (Supplementary Data 14). n (tiles) indicated
above each bar. H3K36me3 tiles that show overlap with H3K4me3 or H3K27me3 were included in the H3K36me3 group. Peaks were called using MACS
peak caller in adult hypothalamus ChIP-seq. e DNA methylation levels over gene bodies marked by low or high levels of H3K36me3. DNA methylation
quantiﬁed over individual gene bodies, excluding promoters. f DNA methylation levels across unmethylated genomic regions (<10% DNA methylation in
wild-type hypothalamus) amongst different genotypes. g, h DNA methylation levels between genotypes over unmethylated regions overlapping low and
high g H3K36me3 or h H3K4me3 marked chromatin. i DNA methylation levels between genotypes over unmethylated regions overlapping low, high
H3K27me3, or both high H3K4me3 and high H3K27me3 (bivalent), marked chromatin. j Scatterplot showing the relationship between gain of DNA
methylation in Dnmt3aΔ/D329A hypothalamus and change in enrichment of H3K27me3. Based on H3K27me3 enrichment difference over DMR tiles
between Dnmt3a+/+ and Dnmt3a Δ/D329A adult hypothalamus. k Scatterplot showing relationship between gain of methylation in Dnmt3aΔ/D329A and initial
levels of H3K27me3 enrichment. l Scatterplot showing relationship between change in gene expression and change in respective gene promoter H3K4me3
enrichment between Dnmt3a+/+ and Dnmt3a Δ/D329A adult hypothalamus. H3K4me3 enrichment was quantitated over gene promoters. In e, g, h, i Low
level: bottom quintile (0–20%) of enrichment;high level: top quintile (80–100%) of enrichment. In e–i, boxplots show median value and 25–75th
percentiles, whiskers show lowest and highest observation, excluding outliers marked by individual points. Raw data are provided in Source Data. In g–i,
histone mark enrichments were quantitated over 100-CpG DMR tiles
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regulation of bivalent chromatin domains and the role of the
DNMT3A PWWP domain. This model will be valuable for
future investigations into the role of DNA methylation
abnormalities in cancer and the growth regulatory function of
DNMT3A.
Methods
Animal experimental procedures and sample collection. All animal experi-
mental procedures were approved by the Animal Welfare and Ethical Review
body at the Babraham Institute, and were conducted under authority of the UK
Home Ofﬁce issued licences in accordance with the Animal (Scientiﬁc Proce-
dures) Act 1986. The Dnmt3aD329A mutant strain was generated by GenOway
Mus musculus GRCm38 chr14:104460728-104470692 (9.9 kbp)
104,461,000 104,465,000 104,469,000
Gene
mRNA
CGI
Hyper-DMR
Pou4f1
+/+
Δ/D329A
+/+
Δ/D329A
+/+
Δ/D329A
+/+
Δ/D329A
+/+
Δ/D329A
+/+
Δ/D329A
H3K4me3
H3K27me3
H3K36me3
input
RNA-seq
WGBS-seq
2
4
6
RPKM
10
30
50
70
90
Methylation (%)
1
3
5
7
RPKM
a
Mus musculus GRCm38 chr4:115043284-115080249 (36.9 kbp)
115,045,000 115,055,000 115,065,000 115,075,000
Gene
mRNA
CGI
Hyper-DMR
Tal1
+/+
Δ/D329A
+/+
Δ/D329A
+/+
Δ/D329A
+/+
Δ/D329A
+/+
Δ/D329A
+/+
Δ/D329A
H3K4me3
H3K27me3
H3K36me3
Input
RNA-seq
WGBS-seq
2
4
6
8
RPKM
10
30
50
70
90
Methylation(%)
1
3
5
7
RPKM
b
Fig. 7 Genomic landscape of de-repressed genes in Dnmt3a Δ/D329A hypothalamus. a, b Representative genome browser views of gene expression,
DNA methylation, and distribution of H3K4me3, H3K27me3, and H3K36me3 marks (determined by ChIP-seq) in adult (14-week) male hypothalamus of
Dnmt3a+/+ and Dnmt3aΔ/D329A genotypes. H3K4me3 and H3K36me3 are enriched over actively transcribed CGI promoters and gene bodies, respectively.
H3K27me3 shows a broad enrichment over transcriptionally silent genes and loss of enrichment upon methylation gain. Genes a Pou4f1 and b Tal1 are up-
regulated and hypermethylated in Dnmt3aΔ/D329A. CGI: CpG island, DMR: hypermethylated region. Each colour-coded block represents: a 50 bp window
with 10 bp step size in the gene expression dataset; a 100-CpG window in the methylation dataset; and 2 kb window with 1 kb step size in the histone
enrichment datasets. For gene and mRNA tracks, the colour indicates direction, where red is a forward strand and blue is a reverse strand. Error bars
indicate standard deviation. n(+/+)= 5, n(Δ/D392A)= 4 for RNA-seq datasets; n= 3 for each genotype in WGBS-seq and ChIP-seq datasets
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(France) by targeting in C57BL/6 ES cells. Brieﬂy, a point mutation GAT to GCT
resulting in aspartic acid to alanine amino acid change at the endogenous locus
of Dnmt3a codon 329 was introduced (Fig. 1a and Supplementary Fig. 1).
Targeting documentation is available upon request. These mice were subse-
quently inter-crossed with C57BL/6Babr mice carrying a conditional Dnmt3a
deletion allele Dnmt3aﬂ and oocyte-speciﬁc Zp3 promoter-driven Cre recom-
binase12. In order to obtain experimental litters Dnmt3aﬂ−/+ Zp3-Cre+ve
females, which carry oocytes with a conditionally deleted Dnmt3aΔ/+ allele, were
crossed with Dnmt3aD329A/+ males; yielding litters with four possible genotypes
Dnmt3a+/+, Dnmt3aΔ/+, Dnmt3a+/D329A, and Dnmt3aΔ/D329A (Fig. 1b). Mat-
ings, conﬁrmed pregnancies, litters and pup numbers were recorded, where the
Dnmt3aD329A allele was passed through the maternal or paternal line in mating
with wild-type C57BL/6Babr mice. Caesarean sections were performed to rescue
the pups if Dnmt3a+/D329A females failed to deliver. When possible, body
weights of experimental litters were recorded at 1.4, 4, 6, 8, 10, and 12 weeks and
analysed using mixed-model ANOVA with post hoc pairwise comparisons using
Bonferroni correction. Litters were sacriﬁced and tissues were collected at
embryonic day 7.5 (E7.5), postnatal day 1 (P1), P25, and adulthood (~14 weeks
old). At E7.5 ectoplacental cone (EPC) and epiblast were collected in PBS and EZ
nuclear lysis buffer (Sigma), respectively.
Genotyping. E7.5 EPCs were lysed in embryo lysis buffer (1M Tris pH8.5, 0.5 M
EDTA pH 8, 10% Tween, 0.2 mg/ml Proteinase K) and used for genotyping by PCR
with primers for Dnmt3awt/ﬂ/Δ alleles (D3A-F 5′-CTGTGGCATC TCAGGGTGAT
GAGCA-3′, D3A-R1 5′-GCAAACAGAC CCAACATGGA ACCCT-3′, and D3A-
R2 5′-TGAGTGGTGA GGCCCAGCTT ATCGA-3′) and Dnmt3aD329A allele
(D329A-F 5′-CAGATCCTTG CCTGAACTGT GGTGC-3′ and D329A-R 5′-TCC
CTCTTGG TCCAGCATGT ACCCT-3′). Adult mice were genotyped by the same
PCR assay using genomic DNA extracted from ear clips, or by service provider
Transnetyx (US) using real-time PCR.
ELISA. Blood samples from experimental animal hearts were collected into
Microvette 500 Z-Gel tubes (Sartstedt), centrifuged for 5 min at 10,000 × g at RT.
Serum collected was used in Rat/Mouse Growth Hormone ELISA kit (Millipore)
and Quantikine ELISA for Mouse/Rat Igf-1 kit (R&D systems) as per manu-
facturers’ instructions.
RNA-sequencing library preparation. Total RNA from 14-week-old animal
hypothalami was extracted using TRIzol (Invitrogen) and cleaned using RNA
Clean and Concentrator (Zymo research) and Ribo-Zero rRNA removal kit
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Fig. 8 CpH methylation in hypothalamus of Dnmt3a+/+ and Dnmt3aΔ/D329A mice. a Representative genome browser view of CpH methylation in adult (14-
week) male hypothalamus. Methylation levels appear to be dependent on the number of alleles present, with a decrease observed in Dnmt3aΔ/+ compared
to Dnmt3a+/+. Notably, there is an increase of methylation over hyper-DMR regions (highlighted by the box) in the presence of Dnmt3aD329A. Each bar
represents a 1000-CpH tile. For gene and mRNA tracks, the colour indicates direction, where red is a forward strand and blue is a reverse strand. CGI: CpG
island, hyper-DMR: hypermethylated region. n(+/+, Δ/+, Δ/D329A)= 3, n(+/D329A)= 2. Error bars indicate standard deviation. b Global mean CpH
methylation values across different genotypes. cMean CpH methylation values over DMRs with CpG hypermethylation. b, c 1000-CpH tile quantitation for
chromosomes 2 and 11 was used as representative. Error bars indicate standard error of the mean. Pairwise comparisons were done using a two-tailed
t-test. Raw data are provided in Source Data. d Barplot indicating the net difference in mean CpH methylation between hyper-DMRs and global levels for
Dnmt3a+/+ and Dnmt3a Δ/D329A mice across development (E7.5 epiblast, P1, P25, and adult hypothalamus). Raw data are provided in Source Data
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(Illumina). Libraries were generated using NEBNext Ultra RNA library preparation
kits (New England Biolabs). RNA-seq libraries were sequenced 50 bp single-end
using Illumina HiSeq2500 platform.
RNA-seq analysis. RNA-seq data was trimmed using TrimGalore 0.5.083, then
mapped using HiSat2 2.1.084 to Mus musculus genome GRCm38. Processed data
was analysed using Seqmonk 1.42.085. Reads over transcripts were merged across
exons correcting for feature length, quantitated using RNA-Seq quantitation
pipeline, and log2-transformed. Differentially expressed genes were called using
DESeq with signiﬁcance threshold of p < 0.01 after Benjamini–Hochberg multiple
testing correction. Mitochondrial genes were excluded. For genome browser views
of gene expression selected regions were split into 500 bp bins every 50 bp and
quantitated as reads per million transcripts, unless speciﬁed otherwise. David 6.786
Functional Annotation Tool was used for gene ontology analysis, with categories
GOTERM_BP_FAT, GOTERM_CC_FAT, GOTERM_MF_FAT, using Benjamini-
corrected p < 0.01 signiﬁcance cut-off.
PBAT sequencing library preparation. Post-bisulphite adaptor tagging (PBAT) was
used to generate genome-wide DNA methylation proﬁles. Approximately 50 ng of
gDNA or 10% of MNase-digested E7.5 Epiblast DNA, puriﬁed using solid phase
reversible immobilisation (SPRI) beads, was used as an input material. Brieﬂy, Imprint
DNA modiﬁcation kit (Sigma) one-step procedure was used to bisulphite-convert the
DNA. First strand synthesis was done using Klenow exo-tagged (New England Bio-
labs) and biotin-tagged Illumina 9 bp random sequence adaptor, followed by Exo-I
treatment (New England Biolabs) and SPRI puriﬁcation. Biotinylated DNA was
captured using Dynabeads Strepatavidin M-280 beads (ThermoFisher Scientiﬁc) and
second strand synthesis was carried out using reverse Illumina 9 bp random sequence
adaptor, followed by library ampliﬁcation using Phusion HF (Thermo Scientiﬁc) or
KAPA HiFi (Kapa Biosystems) polymerase for 10 cycles. Libraries were quantitated
and quality control checked using Agilent High Sensitivity DNA kit and Kapa Illumina
library quantitation kit, as per manufacturer’s instructions. Libraries were sequenced
using 100 bp single-end for P1, P25, and adult tissues; and 150 bp for E7.5 epiblast
sequencing mode on the Illumina NextSeq500 platform at the Babraham Institute
Sequencing Facility.
Methylation data analysis. Methylation data was trimmed using TrimGalore
0.5.083, deduplicated, mapped to Mus musculus genome GRCm38, and methylation
calls were extracted using Bismark 0.19.187. Processed data was analysed using Seq-
monk 1.42.085. Pituitary datasets were down-sampled to the least covered dataset using
SeqMonk to avoid differential coverage artefacts. Probes were deﬁned as tiles of CpG
positions and quantiﬁed using Bisulphite quantitation pipeline. Tiles in adult hypo-
thalamus were 100-CpGs where at least 10 are covered. In pituitary, liver, E7.5 epiblast
and when E7.5 epiblast data was used in analysis, tiles were 300-CpG where at least 10
are covered. Mitochondrial genes were excluded from analyses, X and Y genes were
excluded only from E7.5 epiblast analyses. DMRs were called using Seqmonk edgeR
(for/rev) statistics ﬁlter with absolute methylation difference cut-off of 20%, using
multiple-testing corrected p-value of≤ 0.01. Genomic locations were deﬁned as listed
in the brackets using feature annotations available in SeqMonk: promoter (−1500 to
+500 bp around transcription start site), gene body (+500 bp to the end of the
mRNA/gene), intergenic (promoters and gene bodies excluded). CGI features were
called based on previously published CGI coordinate data88. For promoter analysis,
100CpG windows were fused together if distance between them were <1 kb. For
intergenic regions, adjacent probes were fused together. Random probes were selected
from all probes, excluding those in the DMR list, and utilised as representative of the
genome. Previously described DNA methylation ‘canyon’ coordinates were used in the
analysis60. Only those showing methylation under 10% and covered by at least 5 CpGs
in hypothalamus were used in analysis. Non-CpG methylation was analysed using
1000CpH tiles where at least 30 CpHs were covered.
Ultra-low input native ChIP-seq library preparation. Ultra-low input native
chromatin immunoprecipitation sequencing (ChIP-seq) libraries were generated
using 2.5% of a whole hypothalamus as input for each immunoprecipitation, fol-
lowing previously described protocol89, keeping 10% of that for input. Brieﬂy, cells
were permeabilised using triton X-100/deoxycholate, chromatin was then digested
using micrococcal nuclease (New England Biolabs) and precleared using Dyna-
beads Protein A/G beads (ThermoFisher Scientiﬁc). Antibodies for H3K4me3
(250 ng per reaction, Diagenode C15410003), H3K27me3 (125 ng per reaction,
Millipore 07-449), or H3K36me3 (250 ng per reaction, Diagenode C15410192)
were pre-bound to Protein A/G beads and incubated with chromatin for immu-
noprecipitation. Bound DNA was puriﬁed by SPRI puriﬁcation. MicroPlex Library
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DNMT3APRC2
PRC2 TETs
TETs
DNMT3AD329A DNMT3AD329ADNMT3AD329A
H3K4me3
H3K27me3
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b
Fig. 9 Model of molecular mechanisms acting at bivalent domains. a Representation of current understanding of bivalent domain regulation. The PRC2 complex
deposits H3K27me3 and compacts chromatin across the promoters and surrounding regions of transcriptionally silent, developmental genes62. TET proteins are
recruited, which result in active removal of DNA methylation and protection of bivalent chromatin from de novo DNMTs71. DNMT3A is recruited to bivalent
chromatin shores through an unknown mechanism, enabling active establishment of DNA methylation at the boundaries60,70,71. Through the competing actions
of TETs and DNMT3A there is a cycle of DNA methylation turnover at the boundaries of bivalent domains. b Representation of bivalent chromatin dynamics in
the presence of DNMT3AD329A. The mutant protein is able to access bivalent chromatin and establish methylation across the whole domain. The presence of
DNA methylation appears to inﬂuence the local chromatin environment and results in reduction of H3K27me3, potentially due to exclusion of PRC2 from
methylated DNA. As a consequence, some genes become de-repressed and show an increase in promoter H3K4me3, while others maintain their transcriptional
silencing, this is likely dependent on the availability and strength of necessary transcription factors
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Preparation kit v2 (Diagenode) was used as per manufacturer’s instructions to
generate libraries of inputs and immunoprecipitated samples. Libraries were
quantitated and quality control checked using Agilent High Sensitivity DNA kit
and Kapa Illumina library quantitation kit, as per manufacturer’s instructions.
Libraries were sequenced using 75 bp single-end sequencing on the Illumina
NextSeq500 platform at the Babraham Institute Sequencing Facility.
ChIP data analysis. ChIP-seq data was trimmed using Trim Galore 0.5.083 and
mapped against Mus Musculus GRCm38 genome with Bowtie 1.2.290. H3K27me3
enrichment was quantitated using 2 kb tiles with a 1 kb step, correcting for total count
based on the largest library, unless stated otherwise. H3K4me3 and H3K27me3 peaks
were called using MACS peak caller within SeqMonk 1.42.0, using a signiﬁcant
threshold of p < 0.00001, a sonication fragment size of 1 kb, and input controls as a
reference. When assessment of histone marks was done in relation to DNA methy-
lation, DNA methylation tiles were used to quantitate the enrichment.
Statistical analyses. All measurements taken were biological and not technical
replicates, replicates represent individual animals. Basic statistical tests used are
described in ﬁgure legends where applicable.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Sequence data that support the ﬁndings of this study have been deposited in Gene
Expression Omnibus with the primary accession code GSE117728. All data generated
and analysed in this study are included in the published article and its supplementary
ﬁles and are available from the corresponding author upon reasonable request. Source
data for Figs. 1c, 2a, 3a, 4a, b, 6e–i, 8b, c and Supplementary Figs. 3, 4a, 4c, d, 5a, b, 11a,
11f–i are provided. Source data for Figs. 2c, d and 5b are provided in Supplementary
Data. A Life Science and ChIP-Seq Reporting Summary for this article is available.
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